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CHEMISTRY AND BIOLOGICAL ACTIVITY OF ANTHRAQUINONES 




NOR HADIAN I  ISMA IL  
February 1999 
Prof. Dr. Md .  Nord in Hj . Laj is 
Science and Environmental Studies 
Morinda ellipfica or local ly known as "mengkudu kecil" is a medicinal plant 
commonly used by the Malays in  Peninsular Malaysia. The p lant parts are used in 
various ways to treat many health problems and a i lments . Literature search did not 
reveal any reports on its chemical constituents or biological activity . So, it is bel ieved 
tl1at th is is the first study on the chemical constituents and biological  activity of 
Morinda ellipfica. 
Phytochemical studies on roots of this plant have resulted in the isolation of 
a new anthraquinone, 2-formyl-1 -hydroxyanthraquinone, and ten known 
anthraqu inones, 1 -hydroxy-2-methylanthraqu inone, nordamnacanthal ,  
damnacantha l ,  l ucidin-w-methyl ether, rubiadin ,  soranj id iol ,  morindone, rubiadin-1 -
methyl ether, morindone-5-methyl ether and a lizarin- 1 -methyl ether. The structures 
of the anthraquinones were establ ished based on spectral studies using ultraviolet-
visible spectroscopy, infrared spectroscopy, one and two d imensional nuclear 
magnetic resonance spectra, and mass spectrometry. 
X'Vl 
The new anthraquinone, 2-formyl-1 -hydroxyanthraquinone ,  was synthesized 
through a four step synthesis from phthal ide anhydride and 4-bromophenol .  The 
steps involved a Friedel-Crafts condensation of the starting material to form the 
anthraqu inone rings fol lowed by debromination and methylation before an oxidation 
step to the targeted aldehyde. 
Studies on the b iological activity of the anthraquinones were conducted 
using some selected bioassay procedures. The anthraquinones were subjected to a 
battery of bioactivity testings, which included antimicrobia l ,  antiv ira l ,  cytotoxicity and 
antioxidant assays. The results of these tests indicated that some of the compounds 
do possess interesting biological activity especial ly in  the cytotoxicity and antioxidant 
assays. Damnacanthal and nordamnacanthal were found to be active against many 
cell l ines tested and may have potential to be developed as anticancer agents. 
:-"'Vll 
Abstrak d isertasi yang d ikemukakan kepada Senat Universiti Putra Malays ia 
bagi memenuhi keperluan Ijazah Doktor Falsafah.  
KAJIAN KIMIA DAN KEAKTIFAN BIOLOGI ANTRAKUINON DARIPADA 




NOR HADIANI  ISMAIL 
Februari 1 999 
Prof. Dr. Md .  Nordin Hj . Laj is 
Sains dan Pengajian Alam Sekitar 
Morinda elliptica, atau lebih d ikenali oleh penduduk tempatan sebagai 
mengkudu keci l ,  ialah sejenis tumbuhan ubatan yang kerap digunakan oleh orang-
orang Melayu d i  Semenanjung Malaysia .  Bahagian-bahagian pokok ini d igunakan 
dalam pelbagai cara untuk merawat ban yak masalah kesihatan dan penyakit. Kajian 
l iteratur t idak mendedahkan apa-apa laporan tentang kandungan kimia ataupun 
keaktifan b iologi tumbuhan ini .  Jad i ,  adalah dipercayai bahawa kaj ian kandungan 
kimia dan keaktifan b iologi ini adalah yang pertama kal i  d i lakukan ke atas Morinda 
elliptica . 
Kajian fitokimia ke atas akar tumbuhan in telah berakhir dengan pemenci lan 
satu antrakuinon baru ,  2-fomi l- 1 -hidroksiantrakuinon, serta sepuluh antrakuinon 
yang telah d iketahui, 1 -h idroksi-2-metilantrakuinon, nordamnakanta l ,  damnaka ntal, 
lusidin-m-metil eter, rubiadin ,  saranj idiol ,  morindon , rubiadin-1 -metil eter, mori ndon-
5-metil eter dan a l izarin- 1 -metil eter. Struktur-struktur antrakuinon tersebut dikenal 
pasti berdasarkan kaj ian spektroskopi menggunakan spektroskopi  ultra lembayung-
nampak, spektroskopi inframerah ,  spektroskopi resonan magnetik nuklear satu dan 
dua d imensi ,  serta spektroskopi j is im.  
xviii 
Antrakuinon yang baru, 2-fomil-1-hidroksiantrakuinon, telah disintesiskan 
rnelalui sintesis empat langkah bermula dengan ftalik anhidrida dan 4-bromofenol. 
Langkah-Iangkah tersebut melibatkan kondensasi Fridel-Craft bahan permulaan 
untuk menghasilkan gelang anthrakuinon, diikuti dengan pendebrominan serta 
pemetilan sebelum satu langkah pengoksidaan untuk menghasilkan aldehid yang 
dirancang. 
Kajian keaktifan biologi ke atas antrakuinon-antrakuinon yang diperolehi 
dilakukan menggunakan beberapa kaedah biocerakinan yang terpilih. Kaedah­
kaedah tersebut termasuklah ujian antimikrob, ujian antivirus, ujian sitotoksik serta 
ujian antioksidaan. Keputusan ujian-ujian ini menunjukkan sebahagian daripada 
sebatian-sebatian ini mempunyai sifat keaktifan biologi yang menarik, terutamanya 
dalam ujian-ujian sitotoksik dan antioksidaan. Damnakantal dan nordamnakantal 
didapati aktif terhadap beberapa talian sel yang diuji serta berpotensi untuk 




"Plant in a good soil grows by the will of its Lord" 
[7:58J Surah AI 'araf 
General 
God given Nature provided humans with sources of many essentia ls of life; 
food, medicines, and raw materials for the manufacturing of clothing and shelters. 
Higher plants in particular, have been the source of medicinal agents since earliest 
times. Today, they continue to play a dominant role in the primary health care of 
about 80% of the world's population (Farnsworth et al., 1985). More than 50% of a l l  
drugs currently in use are of natural product origin (Balandrin et al., 1993) . Of the 
world's 25 best selling pharmaceutical agents, 12 are natural product-derived (O'neil 
and Lewis, 1993) . Research into the chemical and biological properties of natural 
products over the past two centuries has resulted in the discovery of many drugs for 
the treatment of human ailments. It has a lso provided the stimulus for the 
development of modern synthetic chemistry. 
Pioneering studies on the active constituents of Podophyllum peltatum L. 
fol lowed by discovery and development of the antileukemic agents, vinblastine and 
vincristine, from Catharanthus rose us L. p rovided convincing evidence that plants 
could be sources of novel, potential chemotherapeutic agents (Baker et al., 1995) . 
Discovery of taxol and camptothecin was the result of NC l's systematic effort in 
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collecting and screening plants for antitumour activity (Cragg et a/., 1993). Taxol has 
now been approved to be used for the treatment of ovarian and breast cancer 
(Kingston, 1 993). Camptothecin ,  on the other hand, has been converted to several 
analogues through semi-synthesis. Some of the analogues are showing promise in 
advanced clin ical trials (Wall and Wani ,  1 993). Table 1 . 1  l isted some of the 
important pharmaceutical agents that are of natural product orig in .  
Table 1 .1 : Some Pharmaceuticals of Plant or Microorganism Origin 
Pharmaceuticals Sources 













T etracycl i ne 
Ephedrine 
Colchicine 

















I n  spite of many successful developments in synthetic chemistry, the 
potential of higher plants as sources for new drugs is sti l l  not exhausted. Of the 
estimated 250 000 existing plant species world wide, only a small percentage has 
been investigated for the presence of bioactive compounds. Very l ittle is known 
about the plants secondary metabolites; and this is especially true for tropical flora. 
Tropical flora constitute over 60% of the estimated 250 000 higher plant species. 
Given the rapid destruction of tropical habitats especial ly the rainforests, this 
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potential loss of knowledge and useful products is alarming. Considering that the 
1 1 9 plant-derived drugs commonly in use in one or more countries were isolated 
from only about 90 plant species (Farnsworth, 1 993), the potential for drug discovery 
from plants and other natural sources is enormous. 
Besides its vast and diverse flora, the tropical rainforest with its humid 
climate, also store immense variety of insects, bacteria and fungi .  Such co-existence 
creates interaction between living organisms occupying the same habitat. Thus it 
can be expected that plants through evolution are able to produce high ly active, low 
molecular weight compounds as defence compounds. These compounds are of 
special interest in the development of new medicinal agents. The interests showed 
by the various organisations through out the world especially National Cancer 
Institute of USA illustrate the importance of the chemical constituents of higher 
plants from tropical rainforests. I n  September 1 986, NCI in itiated plant and marine 
invertebrate collections through contracts with several organisations. Currently the 
collections are being carried out in more than 25 countries, situated mainly in 
tropical and subtropical regions (Baker et al., 1 995). 
Natural Product Research in Malaysia 
Malaysia being located in the tropical belts still maintains quite a substantial 
area of tropical rainforest despite the rapid developments that is taking place in the 
country. Its rainforest stores a large collection of plant species, which is important as 
the source of traditional medicine. It is estimated that there are about 1 0  000 
species of higher plants and about 2000 species of lower plants available in 
Peninsular Malaysia with approximately sixteen percent of these claimed to be used 
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for medicinal purposes (Lattif, 1 984) and has potential to be developed into various 
useful natural products. 
The earl iest records on the use of plants as medicine in Malaysia were g iven 
by Burki l l  and Haniff ( 1 930) , Burki l l  ( 1 935) and Gim lett and Burki l l  ( 1 930) . However, 
chemical studies on Malaysian plants only began in the late fifties when Douglas 
and Kiang publ ished their first phytochemical survey report (Douglas and Kiang , 
1 957) . This was the beginning of natural product chemistry research in Malaysia. 
Since then,  several other surveys were conducted and reported by Carrick ( 1 968) , 
Chan (1 969), Chan (1 972) and other groups (Rahmani ,  1 985) . Nakanishi ( 1 965) not 
only reported on phytochemical survey, but also included pharmacological 
screenings. 
Currently, natural product chemistry is an active field of research in  Malaysia. 
Phytochemica l  screenings are being conducted routinely by various research 
groups.  The reasons are obvious. The country has a rich and d iverse floral heritage, 
most of which has not been fu l ly investigated and are waiting to be d iscovered. This 
is further enhanced by the blend of its multiracial societies , which stores broad 
traditional knowledge about the folkloric uses of many plants for health care and 
other purposes. It is expected that research in this area can generate new 
knowledge and information about the plants not found in other parts of the world .  An 
example is the isolation of calanolide A, a compound that was shown to possess 
anti-H IV activity from Ca/ophyllum lenigerum (Kashman ef a/. , 1 992) found in 
Sarawak. 
In the Natural Products Laboratory of UPM,  the study on the alkaloid content 
of Alseodaphne perakensis (Lauraceae) (Lajis ef a/. , 1 989; 1 99 1 ;  1 992) , Psychofria 
rostrata (Rubiaceae) (Lajis et a/. , 1 993; Mahmud et a/., 1 993), Breynia coronata 
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(Euphorbiaceae) (Lajis ef al., 1 992; 1 995) , Ophiorrhi;UNl�7 lin _�n�A": 
fomenfosa (Hamzah ef al., 1 994; Arbain ef al., 1 993) , Lerchea bracfeata (Arbain ef 
a/. , 1 992) and a number of Hedyotis species (Hamzah et a/., 1 994; 1 997; Ahmad et 
al., 1 996) have revealed several interesting new compounds some of which showed 
rather interesting biological activities such as analgesic activity, cytotoxicity as well 
as antimicrobial and antiviral activities. Screening of local plants collected from 
various parts of the country for biological activities are done routinely as part of the 
natural products research program in the university. The species studied in this 
project was selected based on the results of one of the screening programs. 
Isolation of Biologically Active Compounds from Higher Plants 
Phytochemical investigation will provide data on the chemical constituents of 
the plant concerned . However, many new natural compounds were isolated , 
characterised and published without any biological testing (Meyer ef al., 1 982) and 
their useful biological activities can remain unknown for a long time. The significance 
of the phytochemical work is greatly increased if the fine chemicals isolated from the 
plant possess certain biological activity, particularly i f  the activity is in line with the 
development of medicinal agents. So, the objective of most research in this area is 
now focused on obtaining biologically active compounds. This is made possible with 
the! aid of simple bioassays that can be used in screening crude plant extracts for 
biological activity. Once the biological activity of a plant extract has been confirmed, 
fractionation and separation procedures that lead to the isolation of the active 
compounds can be performed. 
So, if the aim of the work is to isolate bioactive compounds, the use of some 
form of bioassay in screening and fractionation of samples is  crucial. A reliable 
general bioassay system that can detect a broad spectrum of pharmacological 
